[go: up one dir, main page]

MX2012015063A - Metodos y composiciones para mejorar la movilizacion de celulas madre. - Google Patents

Metodos y composiciones para mejorar la movilizacion de celulas madre.

Info

Publication number
MX2012015063A
MX2012015063A MX2012015063A MX2012015063A MX2012015063A MX 2012015063 A MX2012015063 A MX 2012015063A MX 2012015063 A MX2012015063 A MX 2012015063A MX 2012015063 A MX2012015063 A MX 2012015063A MX 2012015063 A MX2012015063 A MX 2012015063A
Authority
MX
Mexico
Prior art keywords
stem cells
hsc
circulation
fucoidan
stem cell
Prior art date
Application number
MX2012015063A
Other languages
English (en)
Other versions
MX344304B (es
Inventor
Christian Drapeau
Gitte S Jensen
Original Assignee
Stemtech International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemtech International Inc filed Critical Stemtech International Inc
Publication of MX2012015063A publication Critical patent/MX2012015063A/es
Publication of MX344304B publication Critical patent/MX344304B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención prove un método de uso de fucoidan para mejorar la movilización de células madre en un sujeto, incluyendo células madre hematopoyéticas (HSC) y células madre de médula ósea (BMSC). En una modalidad, una composición combinada de frutas, hongos, microorganismos, fluidos maternales y extractos de los mismos son usados para promover el tráfico de células madre, dando como resultado migración de las células madre a sitios específicos y mantenimiento y reparación dentro de tejidos y/u órganos. En otras modalidades, el método involucra el uso de fucoidan obtenido de especies de algas particulares para soportar la liberación y circulación de HSC, como se demuestra por una circulación incrementada significativamente de HSC en la sangre periférica. La circulación incrementada de HSC y/o BMSC y migración hacia sitios de mantenimiento y los mecanismos de regeneración naturales en el cuerpo. Se provee además un régimen de dosificación para la administración de fucoidan y un método para mejorar la liberación y circulación de células madre.
MX2012015063A 2010-06-28 2011-06-28 Metodos y composiciones para mejorar la movilizacion de celulas madre. MX344304B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35928810P 2010-06-28 2010-06-28
US201061427023P 2010-12-23 2010-12-23
PCT/US2011/042211 WO2012006100A2 (en) 2010-06-28 2011-06-28 Methods and compositions for enhancing stem cell mobilization

Publications (2)

Publication Number Publication Date
MX2012015063A true MX2012015063A (es) 2013-04-03
MX344304B MX344304B (es) 2016-12-13

Family

ID=45441732

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012015063A MX344304B (es) 2010-06-28 2011-06-28 Metodos y composiciones para mejorar la movilizacion de celulas madre.

Country Status (10)

Country Link
US (1) US10159705B2 (es)
EP (2) EP2588119A4 (es)
JP (2) JP2013531012A (es)
KR (1) KR20140011295A (es)
AU (1) AU2011276479B2 (es)
BR (1) BR112012033548A2 (es)
MX (1) MX344304B (es)
MY (1) MY170013A (es)
WO (1) WO2012006100A2 (es)
ZA (1) ZA201300101B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012033548A2 (pt) 2010-06-28 2017-06-20 Stemtech Int Inc métodos e composições para melhorar a mobilização de células-tronco
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
MX2014005652A (es) 2011-11-18 2014-09-01 Stemtech International Inc Uso de foti para potenciar la movilizacion y proliferacion de celulas madre.
SG10201914117QA (en) 2012-05-09 2020-02-27 Cantex Pharmaceuticals Inc Treatment Of Myelosuppression
JP6050033B2 (ja) * 2012-06-05 2016-12-21 日本メナード化粧品株式会社 幹細胞から外胚葉系細胞への分化誘導剤
WO2014011752A1 (en) * 2012-07-11 2014-01-16 Stemtech International, Inc. Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
US9155763B2 (en) 2012-12-06 2015-10-13 StemBios Technologies, Inc. Lgr5+ somatic stem cells
EP2746770A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
AU2014281338A1 (en) * 2013-06-19 2015-11-26 Stemtech International, Inc. Methods and compositions for enhancing stem cell mobilization
TW201920951A (zh) * 2013-06-24 2019-06-01 美商幹細胞生物科技公司 獲得幹細胞及其資料的方法
US20150141901A1 (en) * 2013-11-08 2015-05-21 Alan S. Lichtbroun Low-level laser irradiation of stimulated human stem cells
WO2016133907A1 (en) * 2015-02-17 2016-08-25 Cantex Pharmaceuticals, Inc. Adoptive cell transfer methods
EP3258941A4 (en) 2015-02-17 2018-09-26 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction
WO2020056521A1 (en) 2018-09-20 2020-03-26 Mystem Biotechnologies Inc. Colostrum derived stem cells, neural differentiation, compositions and supplements for enhancing mammalian health
CN109432028A (zh) * 2018-11-30 2019-03-08 广东乾禾药用植物发展有限公司 一种猴头菌胃漂浮片的制备方法
JP7205880B2 (ja) * 2018-12-13 2023-01-17 日本メナード化粧品株式会社 メラノサイト分化誘導促進剤及びその使用方法
CN112806569A (zh) * 2021-01-20 2021-05-18 中科优术(黑龙江)科技产业有限公司 一种具有保护胃黏膜和抗幽门螺杆菌功能的组合物的制备方法与应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2878597B2 (ja) 1994-04-15 1999-04-05 惇 額田 養毛剤
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
JP2003135028A (ja) * 2001-07-27 2003-05-13 Social Excellent Community Kk 健康機能食品
JP3721432B2 (ja) 2002-03-12 2005-11-30 株式会社コムス 海藻を原料とする飲料用食品の製造方法
US20050042314A1 (en) 2003-08-22 2005-02-24 National Yang-Ming University Extracts of Polygonum multiflorum Thunb., and preparation process and uses of the same
US20070122492A1 (en) 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US20060068022A1 (en) 2004-09-29 2006-03-30 Playford Raymond J Bioactive agent compositions for repair of cell injuries
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
AU2006237738B2 (en) * 2005-04-21 2011-09-29 N.V. Nutricia Nutritional supplement for HIV patients
US20080085330A1 (en) * 2005-05-02 2008-04-10 Cyndy Davis Sanberg Compounds for stimulating stem cell proliferation including spirulina
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
JP4839021B2 (ja) * 2005-06-10 2011-12-14 国立大学法人 岡山大学 白血球及び／又は造血幹・前駆細胞動員剤
JP5006877B2 (ja) 2005-06-24 2012-08-22 デザート レイク テクノロジーズ 藍藻類の精製成分および使用方法
CA2640087A1 (en) * 2006-01-25 2007-08-02 Mount Sinai School Of Medicine Methods and compositions for modulating the mobilization of stem cells
JP2009538923A (ja) * 2006-06-01 2009-11-12 サクラ プロパティーズ、エルエルシー フコイダン組成物及び方法
KR20080007698A (ko) 2006-07-18 2008-01-23 전홍일 푸코이단을 포함하는 산후 조리용 식품 조성물
EP2099465A4 (en) 2006-09-21 2011-09-14 Academia Sinica IMPROVEMENT BY REISHI OF HUMAN TISSUE PROGENITOR CELLULAR ADHESION AND DIFFERENTIATION
JP5679663B2 (ja) * 2007-02-23 2015-03-04 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 海藻抽出物からのフコイダン精製のためのプロセスの方法
HUP0700594A2 (en) * 2007-09-13 2009-04-28 Laszlo Szabo Composition and process for the protection and increasing the number of stem cells in the blood circulation and for enhancing p53 gene expression
CN101433313B (zh) * 2007-11-13 2012-05-30 蒋爱芳 一种具有抗辐射功能的保健食品
JP5186253B2 (ja) 2008-03-14 2013-04-17 第一薬品工業株式会社 抗ウイルス活性強化組成物
KR20090099374A (ko) * 2008-03-17 2009-09-22 김명숙 후코이단을 보강한 미역추출물 및 그 제조방법
US8871492B2 (en) 2008-05-02 2014-10-28 Masaki Shirota Anti-dementia substance from Hericium erinaceum and method of extraction
US20100173024A1 (en) 2008-12-01 2010-07-08 LifeSpan Extension, LLC Methods and compositions for altering health, wellbeing, and lifespan
TW201041586A (en) * 2009-05-22 2010-12-01 Du Peng Medicine and its preparation method for treating Parkinson's disease
US20110287061A1 (en) 2010-05-20 2011-11-24 Cathy Beggan Dietary composition and method for promoting healthy hair growth and melanogenesis
BR112012033548A2 (pt) 2010-06-28 2017-06-20 Stemtech Int Inc métodos e composições para melhorar a mobilização de células-tronco
DE202012012873U1 (de) 2011-03-28 2014-02-03 Mary Kay Inc. Topische Hautpflegeformulierungen, die Pflanzenextrakte umfassen
WO2013022788A1 (en) 2011-08-05 2013-02-14 Stemtech International, Inc. Skin care compositions containing combinations of natural ingredients
MX2014005652A (es) 2011-11-18 2014-09-01 Stemtech International Inc Uso de foti para potenciar la movilizacion y proliferacion de celulas madre.
WO2013101713A1 (en) 2011-12-29 2013-07-04 Entia Biosciences, Inc. A nutritional approach to the use of ergothioneine and vitamin d2 for hair, nail and skin growth
WO2014011752A1 (en) 2012-07-11 2014-01-16 Stemtech International, Inc. Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
AU2014281338A1 (en) 2013-06-19 2015-11-26 Stemtech International, Inc. Methods and compositions for enhancing stem cell mobilization

Also Published As

Publication number Publication date
BR112012033548A2 (pt) 2017-06-20
US20130108587A1 (en) 2013-05-02
AU2011276479A1 (en) 2013-01-17
KR20140011295A (ko) 2014-01-28
AU2011276479B2 (en) 2015-06-25
ZA201300101B (en) 2014-03-26
US10159705B2 (en) 2018-12-25
MY170013A (en) 2019-06-20
WO2012006100A2 (en) 2012-01-12
EP2588119A2 (en) 2013-05-08
EP3153173A1 (en) 2017-04-12
JP2016153430A (ja) 2016-08-25
EP2588119A4 (en) 2014-01-08
MX344304B (es) 2016-12-13
WO2012006100A3 (en) 2012-03-15
JP2013531012A (ja) 2013-08-01

Similar Documents

Publication Publication Date Title
MX2012015063A (es) Metodos y composiciones para mejorar la movilizacion de celulas madre.
GT201400043A (es) Imidazopiridazinas sustituidas con amino
ES2544967T3 (es) Formulación y método para la prevención y el tratamiento de las metástasis óseas o de otras enfermedades óseas
MX2019000547A (es) Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas.
BR112015011244A2 (pt) Análogos de compstatina de ação prolongada, método de fabricação e uso dos mesmos, bem como composição de qualidade farmacêutica
CO6720961A2 (es) Imidazopiridazinas sustituidas
MX394291B (es) Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel.
MX2015017555A (es) Metodos y composiciones para aumentar la movilizacion de las celulas madre.
WO2013070881A8 (en) Method for elimination of space through tissue approximation
ECSP15001113A (es) Composiciones y métodos para mejorar la movilización y proliferación de células madre similares a blastómeros
BR112014008700A2 (pt) composições úteis no tratamento de nefropatia e processos para preparação das mesmas
BRPI0921726B8 (pt) método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero
MX339624B (es) Composiciones mejoradas de celulas y metodos para preparar las mismas.
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
PH12013502399B1 (en) Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
NI201100082A (es) Compuestos de isoindolina para uso en el tratamiento de cáncer.
CO6761392A2 (es) Administración de proteínas a partir de microportadores de células madre
AR077333A1 (es) Anticuerpos humanos de alta afinidad para la angiopoyetina -2 humana
WO2009089110A3 (en) Methods for repair and regeneration of bone marrow
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
BR112012028711A2 (pt) métodos para a fabricação de uma emulsão de óleo em água, para a preparação de um kit de vacina e para redestilação de uma composição compreendendo 99% de esqualeno ou mais, assim como emulsão de óleo em água e kit
CL2007001711A1 (es) Compuestos derivados de pirazolopiridina sustituida;composicion farmaceutica que los comprende;metodo de preparacion de los compuestos ,compuestos intermediarios;y su uso en el tratamiento de enfermedades,tales como tumores,artritis reumatoide,enfermedades del crecimiento vascular desregulado, entre otras.
AR084652A1 (es) Glicoles como agentes inactivadores de patogenos
AR060827A1 (es) Metodo para bloquear la infeccion por flavivirus, moleculas y usos
BR112012022337A2 (pt) composição e respectivos método de preparação e uso de quantidade eficaz

Legal Events

Date Code Title Description
FG Grant or registration